Yang’s research focuses on a new class of drug – PARP inhibitors – that interfere with a cancer cell’s ability to repair DNA damage, hastening cell death.

In honor of Breast Cancer Awareness Month in October, the BCRFA and other organizations are hosting several local events:

UAB's goal is to have 1,201 participate with the intention of breaking the single-site recruitment record of enrolling the most participants.

The chair was established through gifts from the ROAR initiative of the Southeast Cancer Foundation, matched by the University of Alabama Health Services Foundation.

The Multiple Myeloma Clinic was developed by a group of UAB physicians who have a special interest in clinical trial development and the identification of therapeutic and preventive targets.

CPS-3 will enable the general public to help scientists understand the genetic, environmental and lifestyle factors that cause or prevent cancer.